Cargando…
Clinical use of Convalescent Plasma in the COVID‐19 pandemic: a transfusion‐focussed gap analysis with recommendations for future research priorities
BACKGROUND AND OBJECTIVES: Use of convalescent plasma for coronavirus disease 2019 (COVID‐19) treatment has gained interest worldwide. However, there is lack of evidence on its dosing, safety and effectiveness. Until data from clinical studies are available to provide solid evidence for worldwide ap...
Autores principales: | Al‐Riyami, Arwa Z., Schäfer, Richard, van den Berg, Karin, Bloch, Evan M., Estcourt, Lise J., Goel, Ruchika, Hindawi, Salwa, Josephson, Cassandra D., Land, Kevin, McQuilten, Zoe K., Spitalnik, Steven L., Wood, Erica M., Devine, Dana V., So‐Osman, Cynthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891452/ https://www.ncbi.nlm.nih.gov/pubmed/32542847 http://dx.doi.org/10.1111/vox.12973 |
Ejemplares similares
-
How should we use convalescent plasma therapies for the management of COVID-19?
por: Wood, Erica M., et al.
Publicado: (2021) -
Recent advances in transfusions in neonates/infants
por: Goel, Ruchika, et al.
Publicado: (2018) -
Platelet storage duration and its clinical and transfusion outcomes: a systematic review
por: Aubron, Cécile, et al.
Publicado: (2018) -
The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial
por: Estcourt, Lise J., et al.
Publicado: (2019) -
Erratum to “Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk” (Transfusion Medicine Reviews 31/3 [2017] 154-164)
por: Kiely, Philip, et al.
Publicado: (2018)